Simplex Trading’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-367
| Closed | -$1.93M | – | 9513 |
|
|
2020
Q3 | $1.93M | Buy |
367
+338
| +1,166% | +$14K | ﹤0.01% | 1565 |
|
|
2020
Q2 | $96K | Buy |
29
+22
| +314% | +$700 | ﹤0.01% | 4824 |
|
|
2020
Q1 | $19K | Buy |
7
+6
| +600% | +$167 | ﹤0.01% | 6021 |
|
|
2019
Q4 | $1K | Buy |
+1
| New | +$16 | ﹤0.01% | 7168 |
|
|
2019
Q3 | – | Sell |
-9
| Closed | -$11K | – | 8212 |
|
|
2019
Q2 | $11K | Buy |
9
+8
| +800% | +$106 | ﹤0.01% | 6081 |
|
|
2019
Q1 | $1K | Sell |
1
-12
| -92% | -$153 | ﹤0.01% | 7001 |
|
|
2018
Q4 | $14K | Sell |
13
-265
| -95% | -$3.69K | ﹤0.01% | 5644 |
|
|
2018
Q3 | $731K | Buy |
278
+276
| +13,800% | +$7.46K | ﹤0.01% | 2204 |
|
|
2018
Q2 | $4K | Sell |
2
-3
| -60% | -$64 | ﹤0.01% | 6848 |
|
|
2018
Q1 | $2K | Sell |
5
-10
| -67% | -$167 | ﹤0.01% | 5434 |
|
|
2017
Q4 | $1K | Buy |
+15
| New | +$203 | ﹤0.01% | 5779 |
|
|
2017
Q1 | – | Sell |
-3
| Closed | -$3K | – | 7088 |
|
|
2016
Q4 | $3K | Buy |
+3
| New | +$40 | ﹤0.01% | 4883 |
|
|
2015
Q2 | – | Sell |
-9
| Closed | -$3K | – | 6127 |
|
|
2015
Q1 | $3K | Sell |
9
-21
| -70% | -$273 | ﹤0.01% | 3956 |
|
|
2014
Q4 | $2K | Buy |
+30
| New | +$343 | ﹤0.01% | 3878 |
|
Simplex Trading's MNTA Position: Q3 2020 in Review
Simplex Trading sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 323 shares — an estimated $13.4K sold.
Simplex Trading first reported a position in MNTA in Q4 2014 and held it in 13 quarters. The position peaked at $270K in Q1 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.
- Simplex Trading reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Simplex Trading sold 323 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $13.4K.
- Simplex Trading first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 13 quarters.
- Simplex Trading's Momenta Pharmaceuticals, Inc. position peaked at $270K in Q1 2018.
- 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.
Based on Simplex Trading's 13F filing for Q3 2020, filed 14 Oct 2020.